top of page

IN THE NEWS

Tech News in Focus.png

AI.Law v. Butler Labs d/b/a Eve Legal

  • "AI.Law said in the complaint that Eve's technology infringes a ‌patent covering technology for drafting legal documents with AI assistance. The case is one of the first patent disputes between competitors in the fast-growing legal AI sector."
    June 2026 - Reuters.com →
     
  • "On June 17, 2026, AI.Law filed a patent infringement lawsuit against Butler Labs, the company behind Eve Legal, in the U.S. District Court for the Northern District of California (Case No. 3:26-cv-05930). While patent disputes are common in industries such as semiconductors and pharmaceuticals, they remain relatively rare in legal AI...If AI.Law succeeds in enforcing its patent, companies across multiple industries may begin asserting workflow patents rather than competing solely on model performance."
    June 2026 - Intelacia →

Navidea Biopharmaceuticals Shareholder Litigation

  • "For insurance professionals, this case is a wake-up call.  It’s a reminder that D&O policies are only as good as the claims process behind them.  When directors get sued, they expect their insurer to back them up – especially when the stakes are high and the policies spell out clear obligations.  The outcome of this case could shape how insurers handle D&O claims, how exclusions are interpreted, and how future policies are written."
    September 2025 - InsuranceBusinessMag.com →`

AlexSam, Inc. v. Aetna, Inc.

  • “In AlexSam v. Aetna, the Federal Circuit recently revived the patentee's infringement lawsuit against health insurance giant Aetna over its Visa and Mastercard-branded health savings account (HSA) debit cards. AlexSam, Inc. v. Aetna, Inc., No. 22-2036 (Fed. Cir. Oct. 8, 2024)...The case will likely be highly cited by future infringement plaintiffs seeking to overcome motions to dismiss, especially whether allegations in the complaint are unduly conclusory."
    October 2024 - PATENTLYO.com →
     
  • "In the Court’s only precedential patent opinion last week, a panel of the Federal Circuit granted appellant AlexSam a second chance to hold health-care giant Aetna accountable for alleged infringement of its patent claims concerning the use of payment cards in connection with health-care charges....The Federal Circuit vacated those aspects of the dismissal which were challenged on appeal, and found that the license agreement was not dispositive with regard to AlexSam’s claims at the pleading stage. The higher court also disagreed with the district court that AlexSam had failed to plausibly allege infringement by Aetna itself. In the process, the Court expressly held for the first time that a district court’s determination of whether a complaint allegation is “conclusory” for pleading purposes is subject to de novo review, without deference to the lower court’s findings."
    October 2024 - JDSUPRA.com →
bottom of page